---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-052413"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:21:13.789466+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Unicycive shareholders elect four directors and approve reverse stock split at 2025 annual meeting

## Summary
- All four director nominees elected: Dr. Aggarwal, Dr. Gupta, Dr. Laumas, Dr. Kenkare-Mitra.
- Ratification of Grassi & Co. as independent auditor approved (87.8M for, 531.6K against).
- Reverse stock split proposal approved (78.1M for, 9.6M against, 771.4K abstain).
- 69.7% of total voting power was represented at the meeting (88.4M of 126.9M votes).

## SEC filing metadata
- accession: 0001213900-25-052413
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390025052413/0001213900-25-052413-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025052413/ea0245071-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-052413
- JSON: https://secwatch.observer/filing/0001213900-25-052413.json
- Plain text: https://secwatch.observer/filing/0001213900-25-052413.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.